KR890016058A - 4-데메톡시다우노마이시논의 제조방법 - Google Patents

4-데메톡시다우노마이시논의 제조방법 Download PDF

Info

Publication number
KR890016058A
KR890016058A KR1019890004646A KR890004646A KR890016058A KR 890016058 A KR890016058 A KR 890016058A KR 1019890004646 A KR1019890004646 A KR 1019890004646A KR 890004646 A KR890004646 A KR 890004646A KR 890016058 A KR890016058 A KR 890016058A
Authority
KR
South Korea
Prior art keywords
group
demethoxy
daunomycinone
pharmaceutically acceptable
general formula
Prior art date
Application number
KR1019890004646A
Other languages
English (en)
Other versions
KR0136907B1 (ko
Inventor
카브리 왈터
드 베르나르디니스 실비아
프란칼란시 프란코
펜코 세르지오
Original Assignee
지오르지오 오를란도
팜이탈리아 카를로 에르바 에스.알.엘.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지오르지오 오를란도, 팜이탈리아 카를로 에르바 에스.알.엘. filed Critical 지오르지오 오를란도
Publication of KR890016058A publication Critical patent/KR890016058A/ko
Priority to KR97056317A priority Critical patent/KR0142108B1/ko
Application granted granted Critical
Publication of KR0136907B1 publication Critical patent/KR0136907B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

4-데메톡시다우노마이시논의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. (Ⅰ) 하기 구조식 (3)의 4-데메틸-13-디옥솔라닐-디우노마이시논을 N,N-디이소프로필에틸아민 및 촉매량의 4-디메틸아미노-피리딘 존재하에, 일반식(Ⅱ)의 설포닐 화합물과 반응시키고, (Ⅱ) 생성된 일반식(4)의 설폰화된 4-데메틸-13-디옥솔라닐-디우노마이시논을 환원조건하에서 촉매량의 일반식(Ⅲ)의 화합물과 반응시키고, (Ⅲ) 생성된 구조식(5)의 4-데메톡시-13-디옥솔라닐-다우노마이시논으로부터 13-옥소 보호 그룹을 제거시킴을 특징으로 하여, 구조식(Ⅰ)의 4-데메톡시-다우노마이시논물 제조하는 방법.
    상기 식에서, X는 할로겐원자, OS02R그룹, 이미다졸릴 그룹, NH(C6H5)(RSO2)그룹, 또는 페놀과 반응하여 설포네이트를 생성할 수 있는 기타 그룹을 나타내며, R은 하나이상의 할로겐 원자에 의해 임의로 치환된 탄소소 1 내지 10의 알킬그룹이거나 또는 할로겐, 알킬, 알콕시 또는 니트로에 의해 임의로 치환된 아릴 그룹을 나타내고, M은 전이금속원자를 나타내며, L 및 L'는 동일하거나 상이할 수 있고, 음이온 또는 중성분자를 나타내며, n 및 m은 0 내지 4로 변할 수 있다.
  2. 제 1 항의 방법에 의해 제조된 구조식(Ⅰ)의 4-데메톡시-다우노마이시논을 적절한 당 유도체와 반응시키고, 경우에 따라서는, 상기와 같이 수득된 4-데메톡시-다우노루비신을 이의 약제학적으로 허용되는 염으로 전환시킴을 특징으로 하여, 일반식(Ⅳ)의 4-데메톡시-다우노루비신 또는 이의 약제학적으로 허용되는 염을 제조하는 방법.
    상기식에서,
    R1은을 나타낸다.
  3. 제 2 항에 있어서, 당 유도체가 일반식(V)의 화합물인 방법
    상기식에서, Hal은 할로겐원자를 나타내고, R2은 보호된 하이드록시 그룹을 나타내며, R3는 보호된 아미노 그룹을 나타내고, 여기에서, 보호 그룹은 4-데메톡시-다우노마이시논과의 반응후에 제거된다.
  4. 약제학적으로 허용되는 담체 또는 희석제 및, 활성성분으로서, 제2 또는 3항에서 청구된 방법에 의해 제조된 4-데메톡시-다우노루비신 또는 이의 약제학적으로 허용된은 염을 함유하는 약제학적 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890004646A 1988-04-11 1989-04-08 4-데메톡시다우노마이시논의 제조방법 KR0136907B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR97056317A KR0142108B1 (en) 1988-04-11 1997-10-30 Process for preparing 4-demethoxydaunomycinone

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808475A GB8808475D0 (en) 1988-04-11 1988-04-11 Process for preparing 4-demethoxydauno-mycinone
IT8808475.1 1988-04-11

Publications (2)

Publication Number Publication Date
KR890016058A true KR890016058A (ko) 1989-11-28
KR0136907B1 KR0136907B1 (ko) 1998-04-25

Family

ID=10634959

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890004646A KR0136907B1 (ko) 1988-04-11 1989-04-08 4-데메톡시다우노마이시논의 제조방법

Country Status (27)

Country Link
US (1) US5103029A (ko)
EP (1) EP0337665B1 (ko)
JP (1) JP2746997B2 (ko)
KR (1) KR0136907B1 (ko)
CN (1) CN1024000C (ko)
AT (1) ATE85601T1 (ko)
AU (1) AU604405B2 (ko)
CA (1) CA1337762C (ko)
CZ (1) CZ278973B6 (ko)
DE (1) DE68904797T2 (ko)
DK (1) DK170157B1 (ko)
ES (1) ES2045417T3 (ko)
FI (1) FI90411C (ko)
GB (1) GB8808475D0 (ko)
HU (1) HU201772B (ko)
IE (1) IE63713B1 (ko)
IL (1) IL89879A (ko)
MY (2) MY104427A (ko)
NO (1) NO170213C (ko)
NZ (1) NZ228635A (ko)
PH (1) PH25499A (ko)
PT (1) PT90219B (ko)
RU (1) RU1833361C (ko)
SK (1) SK278267B6 (ko)
UA (1) UA19150A (ko)
YU (1) YU47310B (ko)
ZA (1) ZA892560B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8803301D0 (en) * 1988-02-12 1988-03-09 Erba Carlo Spa Process for preparation of 4-demethoxy-daunomycinone aglycone of 4-demethoxy-daunorubicin
GB8808475D0 (en) * 1988-04-11 1988-05-11 Erba Carlo Spa Process for preparing 4-demethoxydauno-mycinone
GB8904794D0 (en) * 1989-03-02 1989-04-12 Erba Carlo Spa Process for preparing anthracyclinones
AUPQ319799A0 (en) * 1999-10-01 1999-10-28 Institute Of Drug Technology Australia Limited Chemical methods
IT1318532B1 (it) 2000-05-19 2003-08-27 Antibioticos Spa Procedimento di sintesi di derivati antraciclinici.
JP4688315B2 (ja) * 2001-02-28 2011-05-25 メルシャン株式会社 ４−デメトキシダウノマイシノンの製造
US7053191B2 (en) * 2003-05-21 2006-05-30 Solux Corporation Method of preparing 4-R-substituted 4-demethoxydaunorubicin
TW200621698A (en) * 2004-08-23 2006-07-01 Sicor Inc Synthesis of idarubicin aglycone
US8802830B2 (en) * 2005-12-20 2014-08-12 Solux Corporation Synthesis of epirubicin from 13-dihydrodaunorubicine
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
US8846882B2 (en) * 2011-04-29 2014-09-30 Synbias Pharma Ag Method of producing 4-demethoxydaunorubicin
CN107698634B (zh) * 2017-09-22 2020-03-10 南京正大天晴制药有限公司 一种盐酸伊达比星的制备方法
CN115616907B (zh) * 2022-09-22 2023-08-04 上海海事大学 一种无人艇航向智能规划方法及控制器

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020270A (en) * 1974-05-02 1977-04-26 Societa' Farmaceutici Italia S.P.A. L-lyxohex-1-enopyranose derivative
GB1467383A (en) * 1974-06-12 1977-03-16 Farmaceutici Italia Daunomycin analogues
US4012784A (en) * 1975-11-28 1977-03-15 Minnesota Mining & Manufacturing Company Voice logging recorder including decks dedicated for both logging and recall operations
GB1527050A (en) * 1976-06-19 1978-10-04 Farmaceutici Italia Optically active anthracyclinones
DE2630237A1 (de) * 1976-07-06 1978-01-19 Blaupunkt Werke Gmbh Verfahren zur herstellung von besser abstimmbaren dickschichtwiderstaenden
US4348388A (en) * 1980-04-02 1982-09-07 G.D. Searle & Co. 11-Amino-11-deoxydaunorubicin and analogs
US4495103A (en) * 1982-07-30 1985-01-22 Sumitomo Chemical Company, Ltd. Preparation of optically active 4-demethoxydaunomycinone
GB8803301D0 (en) * 1988-02-12 1988-03-09 Erba Carlo Spa Process for preparation of 4-demethoxy-daunomycinone aglycone of 4-demethoxy-daunorubicin
GB8808475D0 (en) * 1988-04-11 1988-05-11 Erba Carlo Spa Process for preparing 4-demethoxydauno-mycinone
GB8824947D0 (en) * 1988-10-25 1988-11-30 Erba Carlo Spa New 4-substituted anthracyclinones & process for preparing them

Also Published As

Publication number Publication date
CZ215289A3 (en) 1994-04-13
HUT49624A (en) 1989-10-30
MY104427A (en) 1994-03-31
PT90219A (pt) 1989-11-10
PH25499A (en) 1991-07-24
IL89879A0 (en) 1989-12-15
HU201772B (en) 1990-12-28
ATE85601T1 (de) 1993-02-15
AU3257289A (en) 1989-10-12
NO891457L (no) 1989-10-12
UA19150A (uk) 1997-12-25
EP0337665A3 (en) 1990-04-11
NO170213C (no) 1992-09-23
YU71889A (en) 1991-02-28
DE68904797T2 (de) 1993-05-27
KR0136907B1 (ko) 1998-04-25
ES2045417T3 (es) 1994-01-16
AU604405B2 (en) 1990-12-13
FI891677A0 (fi) 1989-04-10
CA1337762C (en) 1995-12-19
SK215289A3 (en) 1996-06-05
GB8808475D0 (en) 1988-05-11
JPH01308243A (ja) 1989-12-12
US5103029A (en) 1992-04-07
SK278267B6 (en) 1996-06-05
NO891457D0 (no) 1989-04-07
NO170213B (no) 1992-06-15
YU47310B (sh) 1995-01-31
EP0337665B1 (en) 1993-02-10
ZA892560B (en) 1990-12-28
DK170157B1 (da) 1995-06-06
DK169289A (da) 1989-10-12
IE63713B1 (en) 1995-05-31
CZ278973B6 (en) 1994-11-16
CN1024000C (zh) 1994-03-16
NZ228635A (en) 1991-03-26
IL89879A (en) 1993-07-08
RU1833361C (ru) 1993-08-07
PT90219B (pt) 1994-07-29
DK169289D0 (da) 1989-04-07
JP2746997B2 (ja) 1998-05-06
FI90411B (fi) 1993-10-29
FI891677A (fi) 1989-10-12
IE891094L (en) 1989-10-11
CN1038089A (zh) 1989-12-20
EP0337665A2 (en) 1989-10-18
FI90411C (fi) 1994-02-10
MY110352A (en) 1998-04-30
DE68904797D1 (de) 1993-03-25

Similar Documents

Publication Publication Date Title
KR890016058A (ko) 4-데메톡시다우노마이시논의 제조방법
KR880006206A (ko) 퀴나졸리논 유도체 및 이의 제조방법
EP0358154A3 (en) Novel cyclobutane derivative and process for producing same
KR840000528A (ko) 비스-트리아졸 유도체의 제조방법
KR880012526A (ko) l-페닐-3-나프탈레닐옥시프로판아민
KR860006452A (ko) 피페리딘 화합물의 제조 방법
KR890013009A (ko) 2'-데옥시-5-플루오로우리딘 유도체
KR850006938A (ko) 폴루로뮤티린 유도체의 제조방법
KR950704323A (ko) 9-아미노 캄프토테신의 제조방법(Process for the preparation of 9-amino camptothecin)
KR860000243A (ko) 아민유도체의 제조방법
KR830004332A (ko) 린코마이신 및 클린다마이신의 제조방법
KR860008111A (ko) 인딘과 나프탈렌 유도체의 제조방법
ES2033279T3 (es) Procedimiento para preparar un compuesto a base de quinolina.
KR840006482A (ko) 디히드로피라졸로 [3,4-b]피리딘 유도체의 제조방법
ATE113280T1 (de) Eine perfluoralkylgruppe enthaltende verbindung.
DE69029781D1 (de) Anthracyclinglycosid-Derivate und Verfahren zu ihrer Herstellung
KR880007556A (ko) 새로운 안트라시클린 유도체와 이의 제조 방법
KR860003212A (ko) 2-피리딘-티올 유도체 및 그의 산부가염의 제조 방법
KR900014415A (ko) 백금착물 및 활성 성분으로 이를 함유하는 항암제
KR860007276A (ko) 글리코시드 및 그 제조방법
KR880002893A (ko) 5-데옥시-5-플루오로 카나마이신 b 유도체 및 그 제조방법
KR890002217A (ko) 신규 디오스민 유도체의 제조
KR830004265A (ko) 클로로-및 알콕시-치환된-2,4-디아미노퀴나졸린
DK0432527T3 (da) Pradimicinderivater
KR900004727A (ko) 항종양물질, 이의 제법, 및 이를 함유하는 항암제

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20111228

Year of fee payment: 15

EXPY Expiration of term